Laura J. Esserman

Laura Esserman is a surgeon and breast cancer oncology specialist. She is the director of the Carol Franc Buck Breast Care Center at the University of California, San Francisco School of Medicine.[1]

Esserman leads the I-SPY trials, Athena Breast Health Network and the WISDOM study.  Esserman is an inductee in the Giants of Cancer Care, 2018, for Cancer Diagnostics and the “less is more” approach.[2][3][4]

Esserman performs live in the show “Audacity” which she co-created.[5] She is also known as the “singing surgeon” for singing to her patients as they go under anesthesia. 

Early life and education

Esserman attended college at Harvard University and completed medical school Stanford University. After finishing a postdoctoral fellowship in breast oncology at Stanford and earning a master's degree at the Stanford Graduate School of Business, Esserman joined the faculty at UCSF Medical Center in 1993.[6]

Work and research

Esserman is the director of the Carol Franc Buck Breast Care Center.[7] She believes that some patients with a type of breast cancer, ductal carcinoma in situ, should be placed on active surveillance instead of undergoing a biopsy, mastectomy or lumpectomy.[8][9] Dr. Esserman, is one of the most vocal proponents of the idea that breast cancer screening brings with it overdiagnosis and overtreatment.[10][11][12]


Honors and awards

Esserman was named in TIME Magazine's 100 most influential people in the world in 2016.[13] She was a speaker at the first Time 100 Health Summit on October 17, 2019.[14]

In 2019, she was awarded the Simon M. Shubitz Cancer Award and Lectureship from the University of Chicago for her significant contributions to the study of cancer.[15]

She was honored by OncLive for Giants of Cancer Care, 2018, Cancer Diagnosis.[16][17]

References
  1. "Laura J. Esserman, MD, MBA". Retrieved 5 September 2016.
  2. "Who We Are". www.athenacarenetwork.org. Retrieved 2020-04-15.
  3. "Dr. Esserman on Being Named a 2018 Giant of Cancer Care and the "Less Is More" Approach". www.giantsofcancercare.com. Retrieved 2020-04-15.
  4. Eklund, Martin; Broglio, Kristine; Yau, Christina; Connor, Jason T.; Stover Fiscalini, Allison; Esserman, Laura J. (2018-10-01). "The WISDOM Personalized Breast Cancer Screening Trial: Simulation Study to Assess Potential Bias and Analytic Approaches". JNCI Cancer Spectrum. 2 (4). doi:10.1093/jncics/pky067.
  5. "AUDACITY, A World Premiere! – Throckmorton Theatre". Retrieved 2020-04-15.
  6. "Laura Esserman, M.D., M.B.A. Director of the Carol Franc Buck Breast Care Center". Retrieved 5 September 2016.
  7. KGO (2020-02-06). "There may be a more precise and personalized way to screen for breast cancer". ABC7 San Francisco. Retrieved 2020-04-15.
  8. Esserman, Laura. "Time to change how we think about cancer". CNN. Retrieved 2020-04-15.
  9. Pinto, Donna (2015-11-23). "DCIS Over-treatment Makes Mainstream News — 2015 Highlights". DCIS 411. Retrieved 2020-04-15.
  10. Hafner, Katie (2015-09-28). "A Breast Cancer Surgeon Who Keeps Challenging the Status Quo". The New York Times. ISSN 0362-4331. Retrieved 2020-03-31.
  11. "Comparing Two Ways to Schedule Breast Cancer Screenings -- The WISDOM Study". www.pcori.org. 2015-02-18. Retrieved 2020-04-15.
  12. "Iconoclast Dr Laura Esserman Talks Individual Breast Cancer Care". Medscape. Retrieved 2020-04-15.
  13. "Laura Esserman Named to TIME 100 List of Most Influential People in the World". Retrieved 5 September 2016.
  14. "Time 100 Health Summit". Time. Retrieved 2020-03-31.
  15. "Simon M. Shubitz Cancer Prize and Lectureship | University of Chicago Cancer Research Foundation". Retrieved 2020-03-31.
  16. "Laura J. Esserman, MD, MBA Selected as 2018 OncLive Giant of Cancer Care in Cancer Diagnostics". surgery.ucsf.edu. Retrieved 2020-04-15.
  17. OncLive Salutes 21 Visionaries With Giants of Cancer Care Award, retrieved 2020-04-15
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.